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Simulations of antimicrobial peptides in membrane mimics can provide the high resolution, atomistic picture that is necessary to decipher
which sequence and structure components are responsible for activity and toxicity. With such detailed insight, engineering new sequences that are
active but non-toxic can, in principle, be rationalized. Armed with supercomputers and accurate force fields for biomolecular interactions, we can
now investigate phenomena that span hundreds of nanoseconds. Although the phenomena involved in antimicrobial activity, (i.e., diffusion of
peptides, interaction with lipid layers, secondary structure attainment, possible surface aggregation, possible formation of pores, and destruction of
the lipid layer integrity) collectively span time scales still prohibitively long for classical mechanics simulations, it is now feasible to investigate
the initial approach of single peptides and their interaction with membrane mimics. In this article, we discuss the promise and the challenges of
widely used models and detail our recent work on peptide–micelle simulations as an attractive alternative to peptide–bilayer simulations. We
detail our results with two large structural classes of peptides, helical and beta-sheet and demonstrate how simulations can assist in engineering of
novel antimicrobials with therapeutic potential.
© 2006 Elsevier B.V. All rights reserved.Keywords: Antimicrobial peptide; Peptide–micelle simulation; Molecular dynamics; Mechanism of action1. Introduction
The goal of research in the area of antimicrobial peptides
(AMPs) is to reduce the host-cell toxicity levels of active peptides
by intelligent mutations to facilitate the design of novel antibiotic
molecules. Despite considerable progress and advancements in
the use of various experimental and computational techniques, the
scope of rationalizing the design of effective AMPs remains
limited [1]. The key bottleneck in the process is the lack of
availability of molecular details of peptide–lipid interactions that
eventually drive cell-death. It has been oft-repeated that
experiments have not been able to resolve the fast time scales
of peptide–membrane interactions. Molecular dynamics simula-⁎ Corresponding author. Department of Chemical Engineering and Materials
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doi:10.1016/j.bbamem.2006.03.010tions of AMPs with model membranes have led to useful insights
into the types of biophysical interactions that drive peptide–
membrane association [2]. Although the length and time-scales
presently accessible to these simulations limit the amount of
useful molecular information that could be of use to design
efforts, the future of such methods is looking brighter. In the
current article, we will discuss some of our recent work on AMP
simulations in micellar environments. The initial part of the paper
will be devoted to drawing a short summary of the limitations and
scope of some of the recent progress made in all-atom molecular
dynamics simulations of AMP–membrane systems. For a review
of advances made before 2001, please refer to La Rocca et al. [3].
Please note that this article is not a comprehensive review of
peptide–membrane simulations in general; the focus is ultimately
on all-atommolecular dynamics simulations of AMP–membrane
systems.
The mechanism of action of cell-death induced by AMPs
putatively involves initial binding to the membrane, induction
of peptide secondary structure (in most cases), local aggregation
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by membrane destabilization [4]. Unfortunately, limitations on
current computing capacity still preclude the investigation of
peptide aggregation and pore/carpet formation on the mem-
brane. Thus, one of the key goals of simulations is to shed light
on the initial events involved in the binding of an AMP to a
membrane. This involves deduction of the important bio-
physical interactions between the AMP and the membrane, and
the quantification of the effect of peptide binding on membrane
dynamics and structure and vice versa. Based on these ob-
servations, it is possible to identify the role of individual amino
acids in the peptide's interaction with the membrane. In
principle, this information can then be used to design mutants
of the peptide to improve activity against microorganisms, or to
attenuate toxicity against host cells.
Hydrated phospholipid bilayers, surfactant micelles, and
phospholipid monolayers have been used to model membrane
interfaces. Typically, the simulation of a single AMP near a
hydrated model membrane is started with the peptide placed
either in the aqueous phase [5] or positioned in the membrane in
an orientation suggested by experiments [6]. We will refer to
these two types of simulations as type 1 and type 2 respectively.
The former type of simulations have broader scope because the
binding dynamics of the peptide to the membrane can be
investigated. In either case, experiments provide the initial
structure of the peptide. The simulations are usually implemen-
ted in the constant-temperature, constant-pressure (NPT)
statistical ensemble. When lipid bilayers are used as membrane
models, the NPT ensemble must be used in order to allow the
area per lipid in the membrane to adjust to the insertion of the
peptide. However, type 1 simulations of peptides in hydrated
phospholipid bilayers run into convergence problems [5,7]. The
same is true when monolayers are used [8]. One key objective of
an AMP–membrane simulation is to correctly identify the final
binding state of the peptide near the membrane. In order to do so
with a high degree of confidence, it must be shown that different
initial conformations of the peptide lead to a similar final
ensemble of states. Kandasamy et al. found that convergence
was not achieved within time scales of ∼20 ns for magainin
peptides in POPC bilayers [7]. We have carried out simulations
of the helical AMP ovispirin and the β-sheet peptide protegrin-1
near lipid micelles [9–12]. When the peptide starts out in the
aqueous phase, we have found that the final binding orientation
of the peptide depends upon which face (hydrophobic or
hydrophilic) of the amphipathic peptide is initially oriented
towards the micellar interface. On the other hand, Lensink et al.
[13] were able to demonstrate convergence to the same final state
from different starting conformations of the cell penetrating
peptide penetratin in POPC and POPG bilayers. To our best
knowledge, this is the only case of type 1 simulations in literature
where such convergence has been established in NPT simula-
tions of AMPs near lipid bilayers. Unfortunately, the timescales
of convergence these simulations were as high as 290 ns (in
POPC) and 150 ns (in POPG). Although such simulations are
feasible with current computing power, the very long time scales
of convergence set limits on the number of such simulations that
one can implement in a given time frame. Typically, one wants toevaluate and compare the membrane interaction properties of
several different related AMPs in order to identify the role of
specific mutations which differentiate the microbicidal and toxic
properties of the peptides. For the reasons noted above, all-atom
hydrated lipid bilayers are perhaps not the ideal model to
implement a large number of simulations.
In order to overcome some of these shortcomings, we have
implemented simulations of several sets of related AMPs in
zwitterionic dodecylphosphocholine (DPC) and anionic sodium
dodecylsulphate (SDS) micelle systems. As models of membrane
interfaces, micelles offer several advantages over lipid bilayers.
Micelles are useful systems to study the influence of interfacial
membrane electrostatics on the structural properties of small
peptides. The primary advantage of using micelles as opposed to
lipid bilayers is the faster time scales of motion of DPC and SDS
molecules. It has been shown both experimentally [14] and by
simulations [15–18] that the slowest relaxation times of lipids in
micellar solutions are of the order of 500–2000 ps. On the other
hand, the area-per-lipid in bilayers relaxes on timescales of the
order of ∼20000 ps [19]. The micelle contains about 75% the
number of atoms of a typical 128-lipid peptide–water-bilayer
simulation cell. This allows much longer simulations and permits
monitoring of biological phenomena of longer time scales. In our
recent work, we have shown that the micelle model is successful
in capturing experimentally-observed binding states of small
peptides [9–11]. DPC lipids carry a phosphocholine head group
like zwitterionic membrane phospholipids, and the DPC micelle
is thus well suited as a model to study peptide–membrane
interactions on a zwitterionic interface. The head group of the
SDSmicelle is very different from anionic phospholipids, but still
offers an anionic lipid–water interface at which peptide binding,
and changes in peptide structure can be monitored. The most
significant advantage of using spherical micelles as opposed to
planar lipid bilayers is that the need for implementing several
different simulations with different initial conformations is
precluded. We will discuss this in more detail in the methods
section. Indeed, there are several limitations in the use of micelles
asmodels ofmembrane interfaces; and these are pointed out in the
conclusions section.
2. Peptides investigated
We have carried out simulations for several different
cathelicidin antimicrobial peptides. Cathelicidins are one of
the two major families of mammalian AMPs, and cathelicidin
peptides of all three principal structural classes (α-helical, β-
sheet, and unstructured) have been characterized. We have
implemented simulations for each structural class.
2.1. Helical peptides
Helical peptides are the most abundant class of antimicrobial
peptides, and the mechanism of action of various such peptides
has been thoroughly investigated in literature. For representa-
tive examples, please refer to [20,21]. Ovispirin-1 (OVIS) is an
18-amino acid (KNLRR IIRKI IHIIK KYG) helical AMP, and
has significant antimicrobial activity. It is unsuitable for
Table 1
Activity and toxicity of the protegrins discussed in the current paper
Name Sequence Activity
(E. coli)
hemolysis
(%)
cytotoxicity
(μg/mL)
PG-1 RGGRLCYCRRRFCVCVGR 0.9 >50 25–50
PC94 VCYCRRRFCVCVGR 0.6 >50 25–50
PC98 ECYCRRRFCVCVGR 0.7 3–6 50–100
PC101 RGGRLCYCRRRFCVCT 0.7 12–25 100–200
PC104 RGGRLCYCRRRFCVCI 0.6 >50 25–50
PC107 RGGRLCYCRRRFCVCE 0.6 0–3 100–200
PC72 LCYCRRRFCVC 0.6 6–12 50–100
PC73 CYCRRRFCVC 14.1 0–3 200–400
Hemolysis is given by the percent of red blood cells killed at 80 μg/mL of the
peptide. Cytotoxicity is measured as the concentration of peptide required to kill
50% of the human epithelial cells.
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Novispirin G10 (KNLRR IIRKG IHIIK KYG) and Novispirin
T7 (KNLRR ITRKI IHIIK KYG) are single residue mutants of
OVIS which retain the antibacterial activity, but are less toxic.
The three dimensional structures of all three peptides were
evaluated in presence of tri-fluoro-ethanol (TFE) (Fig. 1). The
point mutations led to significant structural changes in the
peptides, inducing a helix kink in G10 and N-terminal flexibility
in T7 [23]. The structural and functional properties of these
three peptides make them well suited to carry out investigations
of the interplay between membrane-influenced peptide structure
and peptide–membrane interactions.
2.2. β-hairpin peptides
The protegrins are a family of five potent, naturally occurring
cationic antimicrobial peptides that were originally purified from
porcine leukocytes [24,25]. They have aβ-hairpin structure that is
held in place by two disulfide bonds. Protegrin-1 [PG-1, RGGRL
CYCRR RFCVC VGR] can launch a rapid response to infection
by diverse bacterial species [26] including Escherichia coli,Fig. 1. Three structural classes of AMPs that we have investigated. (A) The
helical peptide OVIS and its analogues. (B) Protegrin-1, a β-hairpin peptide and
(C) Indolicidin, unstructured (the relative dimensions of the peptides are not to
scale).Candida albicans, and Listeria monocytogenes [24]. We have
obtained data from our co-workers at UCLA, who have created
sixty protegrins based on the sequence of PG-1. They have
provided us with data for the activity for these protegrins against
various microbial species and also cytotoxicity and hemolysis
data. As of now, we have completed simulations of 8 protegrins in
SDS and DPC micelles. For the protegrins we will be discussing
here, these data are shown in Table 1.
2.3. Trp-Pro-rich peptides
We have also carried out simulations of indolicidin (ILPWK
WPWWP WRR), for which no well-defined structure has been
isolated yet. The results from these simulations will be reported
elsewhere.
3. Methods
We have implemented simulations of AMPs in zwitterionic DPC and
anionic SDS micelles. In the case of DPC micelles, the starting coordinates of
the micelle–water complex were obtained from simulations carried out by
Wymore et al. [16]. This structure was obtained after extensive minimization
and dynamics of about 1 ns in a cubic simulation cell. In the case of SDS
micelles, the starting coordinates of the micelle–water complex were obtained
from simulations carried out by MacKerell [27]. This structure was obtained
after extensive minimization and 120 ps of NVT and NPT simulation in a
cubic simulation cell. SDS and DPC were both parameterized using the
CHARMM force field. In either case, the micelle was placed in a cubic
simulation box of cell size 56.15 Å. The cell dimensions were setup so as to
obtain the equilibrium bulk water density (0.033/Å3) far away from the
interface. Water was modeled using the TIP3P potential [28]. 5 Na+ and Cl−
ions were added as 0.15 mM electrolyte. In SDS, chloride counterions were
distributed with random coordinates in the aqueous phase to keep the system
electrostatically neutral.3.1. Initial peptide positioning
In principle, to observe the folding of the peptide on the membrane interface,
the simulation should start with a random coil peptide structure. However, the
very long time scales of peptide folding on membrane interfaces prohibit such
simulations. The peptide structure obtained from experiments, as reported in the
pdb data bank, were used to start the simulations. For protegrins, only the
structure of PG1 is available in the pdb data bank. Homology modeling was used
to obtain the structures for the other peptides.
Solid-state NMR experiments of OVIS in lipid bilayers [29] suggest that the
majority of theOVIShelix is oriented parallel to the interface,with the hydrophobic
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interface to avoid biasing final conformation of the simulation. Instead, each
peptide was placed in the simulation box with its center of mass coinciding with
that of the micelle. In this conformation (CONF1), the peptide helix lay along one
of the diameters of themicelle,with only its termini exposed to the solvent interface
(Fig. 3A and C). Owing to the spherical symmetry of the micelle, the orientation of
the peptide is unimportant, and thus the need to start the simulation from different
starting orientations with respect to the membrane interface is eliminated (Fig. 2).
Simulations were also run with the peptide initially placed in the aqueous phase
(CONF2). The final conformations obtained from unbiased simulations of type
CONF1 were used to bias the initial orientation of the peptide w.r.t. the membrane
interface in simulations of type CONF2. Thus, for each helical peptide in each
micelle, we carried out 2 simulations. One where the peptide is initially placed
along a micelle diameter (unbiased); and the other where the peptide is initially
placed in the aqueous phase, but the initial orientation of the peptide is guided by
the results of the first simulation.
To remove initial bad contacts between the peptide and the micelle core, and
prevent penetration of water, the peptide and bulk water were kept under weak
harmonic constraints with spring constants of 10 and 5 kcal/mol Å, respectively
during equilibration. The constraints were gradually removed in 20,000 steps of
minimization (steepest descent method). The entire system was then minimizedFig. 2. Schematic representation of the simulation of an amphipathic helix in bilayers
are independent, and depend on the initial conformation of the peptide. (B) Because o
Thus, the initial conformation of the peptide is unimportant, precluding the need tofor 20,000 more steps without any constraints. Thereafter, the system consisting
of about ∼16,000 atoms was gradually heated to 303 K. The entire assembly
was subjected to NPT dynamics at pressure P=1 atm and temperature
T=303.15 K for 40 ns. The constant pressure–temperature module of
CHARMM [30] was used for the simulation with a leap-frog integrator. A
time step of 2 fs was used. The temperature was set at 303.15 K using Nose–
Hoover temperature control [31]. For the extended system pressure algorithm
employed, all the components of the piston mass array were set to 500 amu [32].
The electrostatic interactions were simulated using the particle mesh Ewald
(PME) summation [33] without truncation and a real space Gaussian width of
0.25 Å− 1, a β-spline order of 4, and a FFT grid of about one point per Å. The
non-bonded van der Waals interactions were smoothly switched off over a
distance of 3.0 Å, between 9 Å and 12 Å. SHAKE was used to eliminate the
fastest degrees of freedom involving bonds with hydrogen atoms. The
simulations were carried out using CHARMM version c30b2 with the all
atom param22 parameter set. We have shown earlier that unconventional π-
helices are not formed with the param22 parameter sets in peptide-micelle
simulation setups [9]. For calculation of most dynamical properties, trajectories
were sampled every 10 ps.
Simulations with the protegrins were carried out using the same methodology.
For some smaller protegrins, the steady state conformations were achieved withinand micelles. (A) The final conformations A1 and A2 in the bilayer simulations
f the spherical symmetry of the micelle, conformations B1 and B2 are equivalent.
start run multiple simulations from many different starting conformations.
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simulations were carried out using only the CONF1 conformation.
4. Results: helical peptides
4.1. Peptide position and orientation
All three peptides converge to the interfacial-bound steady
state in both types of micelles in nearly 40 ns of simulations
(Fig. 3). In either micelle, the hydrophobic surfaces of the
peptides are embedded in the micellar core, while the
hydrophilic face remains exposed to water and the lipid head
groups. The long axis of the peptide lies parallel to the micelle
surface tangent. For OVIS, these observations are in good
agreement with NMR experiments carried out in lipid bilayers
[29]. At the time this article was being prepared, there was no
experimental data available for G10 and T7.
Fig. 4 shows two indicators of the convergence of the
CONF1 and CONF2 simulations. In Fig. 4a, we have plotted
the distance between the center of mass of the micelle and the
peptide from the two different starting conformations of
OVIS in DPC micelles. In Fig. 4b, the orientation of the
peptide w.r.t. the micelle is plotted for the same set of
simulations. The orientation of the peptide w.r.t. the micelle
was measured by calculating the angle between the peptideFig. 3. Initial (left) and the final (right) conformations of the OVIS in DPC. A and B a
t=39 ns. T7 and G10 also have similar final conformations. The same binding orienta
with the peptide placed in the aqueous phase.helical axis, and the vector from the center of mass of the
micelle to the center of mass of the peptide. Throughout the
simulations, the peptide remains more or less parallel to the
surface of the micelle. In either case (CONF1 or CONF2), the
peptides diffuse to the interface bound conformation within
20–25 ns. The simulations were run for another ∼20 ns,
during which the position and structure of the peptide did not
change significantly. The last 10 ns of each simulation were
used to calculate ensemble averaged properties. Most of the
results presented for this section will be from the more recent
CONF2 simulations.
Importantly, simulations of type CONF1 and CONF2 both
lead to the same final peptide conformations and orientations.
The convergence has similar trends for all three peptides, in
both types of micelles. There are only slight differences in the
backbone dihedral angle values, and these do not significantly
affect the position of each residue in the Ramachandran plot
(data not shown).
The binding depths of the peptides are similar in SDS, which
correlates with their equally potent antibacterial properties.
However, OVIS, the most toxic peptide, is embedded deepest
into the DPC micellar interface (Fig. 5). G10 and T7, on the
other hand, are less buried in the DPC micelle. The relative
depths of insertion in DPC micelles correlate well with the more
toxic properties of OVIS, and the lower toxicity of G10 and T7.re side views, while C and D are top views. Snapshots were taken at the t=0 and
tions are obtained for each of the three peptides when the simulations are started
Fig. 4. (a) Time profile of the distance between the center of mass of the peptide
and the micelle. (b) Time profile of the angle between the peptide helical axis
and the vector from the micelle center of mass to the peptide center of mass. The
data for both plots are from the OVIS in DPC CONF2 simulations.
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A clustering algorithm of peptide backbone dihedral angles
(ϕ,ψ) was implemented in order to check if new peptide
conformations were observed in the production period. Time
series of the peptide dihedral angles were obtained from different
initial timepoints tini in the trajectory. tini was varied from
tini=0 ns to tini =33.6 ns with a 2.4 ns interval. Thus, each set of
time series contained the dihedral angle values for the peptide for
a trajectory window starting at time tini, till the end of theFig. 5. The electron densities of the three peptides relative to the average electron
densities of the phosphates in DPC. The abscissa is the distance from the center
of mass of the micelle. The plot reflects the relative binding depths of the three
peptides in DPC. These data are from the CONF2 simulations.simulation. Each set of time series was clustered using the ART-
2 clustering algorithm in CHARMM. The number of clusters
thus obtained is a good measure of the number of different
peptide conformations observed during a trajectory window.
The results of this clustering analysis for the CONF2 DPC
simulations are shown in Fig. 6. The simulationwas run for 44 ns
in this case. No new peptide conformations are sampled during
the production period of the simulation for any of the three
peptides. The peptide G10 does form 2 clusters at tini=31.2 ns.
However, the cluster disappears if a slightly larger cluster radius is
chosen, indicating that the 2 clusters are very close to each other,
and represent very similar peptide conformations.We believe that
such a calculation is an excellent indicator of the approach of a
simulation towards peptides' conformational equilibrium. Addi-
tionally, at tini=0, T7 and G10 have a higher number of clusters
than OVIS, indicating that these two peptides sample a much
larger variety of conformational states during the full course of
the simulation, which correlates with their greater flexibility.
The helical structure of OVIS was further stabilized compared
to its experimental structure in TFE, as the peptide diffused to the
interface. All the (i,i+4) backbone–backbone hydrogen bonds
were satisfied, leading to a compact interface-bound helix which
lay parallel to the interface (Figs. 3, 7).On the other hand, bothG10
and T7 became less helical in DPC micelles. The experimental
TFE-induced structure of G10 has a bend as positions 12 and 13
induced by inclusion of a glycine at position 10 [23]. The bend in
the G10 helix in DPC extended from positions 7 through 11. This
results in partial unfolding of the secondN-terminal helix turn. The
flexibility is enhanced in presence of the DPC micelle. Residue 6
(Ile) also acquires non-native dihedral angles.
The structures of the three peptides are as helical in SDSmicelle
simulations as they are in the experimentally obtained structures in
TFE. The SDS lipids do not induce any unfolding of the helices. In
fact, the helices in SDS are tighter and conform better to the native
helical (φ, ψ) pair value of (−50, −60) (data not shown).
The structure of OVIS remains amphipathic in the presence of
either DPC or SDSmicelles. However, the less toxic G10 and T7
become less amphipathic in DPC micelles. The reducedFig. 6. The number of clusters of peptide dihedral angles. Each data point at
time t= tini corresponds to the number of clusters of peptide dihedral angles
calculated by a clustering of the time series of dihedral angles. The time series
is obtained from a trajectory window from time t= tini till the end of the
simulation. Each cluster of peptide dihedral angles represents a unique peptide
conformation.
Fig. 7. Initial and final secondary structures of the peptides in DPC micelles in
the CONF2 simulations.
Fig. 8. Radial distribution functions drawn between the positively charged
amino acid side chains and the phosphate groups (in DPC) and the sulfate groups
(in SDS). The functions were normalized by an arbitrary density of 0.01 and by
the number of atoms in the first selection.
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hydrophobic residues with the DPC micellar core, (as revealed
by radial distribution functions), eventually leading to weaker
binding to the DPC micelle. The implications of these subtle
changes in secondary structure are expounded upon in the next
section.
Interestingly, the binding behavior of charged residues of
OVIS to the DPC vs. the SDS micelles was qualitatively similar.
In either case, radial distribution functions (rdfs) revealed
formation of hydrogen bonds between the positively charged
amino acid side chains and either the phosphate oxygens in
DPC, or the sulfate oxygens in SDS. However, the relative
heights of the peaks indicate stronger H-bonds and interactions
in SDS. This is to be expected from the differences in the
electrostatic surfaces of the two micelles. In DPC, the choline
group can screen the electrostatic interaction between the
charged residues of the peptide and the phosphate groups both
by steric hindrance and by the electrostatic repulsion from the
cationic nitrogen. Similar results are obtained for G10 and T7 as
well. The possible implications of these observations are
discussed in the following section.
5. Discussion: helical peptides
We have implemented MD simulations of an active and toxic
helical AMP and its two active, but non-toxic analogues in
zwitterionic micelles. Simulations were also carried out in SDS
micelles to compare the influence of membrane electrostatics on
peptide secondary structure and toxicity. The goal of the study
was to dissect the differences in the peptides that make the
analogues (G10 and T7) less toxic compared to the native peptide
(OVIS). The simulations converged to their final equilibrium state
with respect to the distance between the center of masses of the
peptide and the micelle, as well as with respect to the orientation
of the peptide w.r.t the micelle. We also confirmed that no new
secondary structural features were appearing during the ensem-
ble-sampling period of the simulations. Moreover, simulations
were started from two very different conformations and
converged to the same final state. Despite these substantiations
to argue for the convergence to the equilibrium conformation in
phase space, there is always a doubt as to whether more samplingis required to guarantee that equilibrium has been achieved, and
that the conformations observed in the current simulations
represent true free energy minima. The results in this work
should be interpreted in this light.
There are no significant differences in the three peptides with
respect to interaction of polar residues with the DPC micelle. The
simulations explicitly demonstrate that hydrophobic interactions
drive the strong association of the OVIS peptide with the DPC
lipids. This observation has been widely documented in literature
for various helical AMPs. The key phenomenon that the
simulations indicate is that the most toxic peptide, OVIS, remains
helical, while the less toxic G10 and T7 lose helicity in presence of
DPC. The stabilization of the helical structure of OVIS in the
presence of DPC lipids allows the hydrophobic residues of the
peptide to bind cooperatively to the micelle. The reduced helicity
induced in G10 and T7 by DPC leads to lower amphipathicity
resulting in a lower depth of insertion into the micelle. For this
reason, G10 and T7 are suggested to be less toxic thanOVIS. Both
G10 and T7 have one less hydrophobic residue than OVIS, and
indeed, this also contributes to the lower toxicity, but ramifications
of the point mutations in G10 and T7 extend well beyond the
reduction of total hydrophobic content. The mutations induce
critical changes in peptide secondary structure that prevents the
cooperative isolation of hydrophobic residues into the membrane
core. The situation is different in SDS micelles, where all three
peptide retain their secondary structure, and remain equidistant
from themicellar center ofmass. The comparable depth of binding
of all three peptides to SDS, and the lesser binding depth of G10
and T7 in DPC correlate perfectly with the high antimicrobial
activity of all three peptides, and the reduced toxicity of G10 and
T7.We still do not have a clear answer to the question “why are the
structures ofG10 and T7more helical in SDS, than in DPC ?”. It is
known that electrostatic interactions between cationic sidechains
of unstructured peptides and the anionic lipid headgroups drive
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rdfs described in Fig. 8 explicitly quantify the stronger attraction
to anionic interfaces, compared to zwitterionic interfaces. It is
possible that a greater degree of adsorption to anionic interfaces
(driven by the strong initial electrostatic force) allows the peptide
to take a more amphipathic helical form. However, such
hypothesis can only be justified when the folding events of
unstructured peptides near interfaces are investigated in simula-
tions, or in experiments. Unfortunately, these simulations are still
not computationally tractable.
It is believed that the electrostatic differences in the
composition of bacterial and mammalian plasma membranes
are responsible for selective toxicity of AMPs. However, be-
sides attracting cationic AMPs, the anionic surface of bacterial
membranes might influence other processes which affect
selectivity. It is known that most AMPs are unstructured in
solution, and achieve their helical form after binding to the
membrane. The extent of helical content induced in an AMP in
the presence of a membrane interface can influence its hemo-
lytic and antibacterial properties. Generally, no comprehensive
attempt has been made to correlate peptide toxicity with the
differences in the abilities of anionic and zwitterionic
membranes to induce secondary structure in AMPs. Our work
tries to fill this void. For a more detailed discussion of these
arguments, please refer to [11]. Based on our simulations and
the above discussion, we suggest that mutations which
marginally lower peptide helical content should reduce toxic
properties by lowering overall peptide amphipathicity. Interest-
ingly, we found at least two such examples in literature. These
are the helical AMPs pleurocidin [34,35] and IsCT and their
analogues [36]. In both cases, less helical mutants were less
toxic to mammalian cells.
6. Results and discussion: β-hairpin peptides
The study of protegrin-1 (PG-1) and its mutants have shown
promise for the potential development of a protegrin-derived
antibiotic peptide. We are currently in the process of simulating
the sixty protegrin mutants for which activity and toxicity data
are available. We have completed simulations of a range ofFig. 9. Initial (A) and final (B) conformatipeptides with varying levels of activity and toxicity and have
begun to determine rules for the design of new protegrins. In
Fig. 6, we show an example of the initial and final
configurations for PG-1 in an SDS micelle.
In our original work with protegrin-1 (PG-1), we found that
Leu-5 plays an integral role in the peptide's interactions with
SDS, but does not interact with the DPC micelle [12]. We saw
that the other side of the β-hairpin, mainly Phe-12 and Val-14
are the residues most involved in the disruption of the DPC
micelle. We have designed a peptide based on these results that
we hope will have a lower toxicity and are presently testing it.
In our work with the much smaller protegrin mutants PC72
and PC73, we found that the presence of the N-terminal leucine
residue on PC72 is responsible for the activity of this peptide
against microbial species (unpublished results). This was the
expected conclusion simply based on the sequences, but we
further examined the individual residues' roles in the toxicity of
PC72 and have determined that the region near Tyr-3, should
have its hydrophobic content reduced to create a less toxic
version of this peptide. We are currently testing peptides based
on this finding.
We have additionally examined several other protegrins [37].
PC101, PC104, and PC107 have the same sequence as
protegrin-1 for the first 15 residues but have different types of
amino acids at the C-terminal end. We have determined that
removing the positive charge from the C-terminus has a
significant impact on the modes of peptide–micelle interactions.
For PC101 and PC104, the second strand of the hairpin inserts
into the SDS micelle, suggesting that these residues play a role
in the antimicrobial activity of these peptides. We have also
examined PC94 and PC98, peptides with have mutations at their
N-termini.
6.1. Insights into activity
Comparing all of the peptides for which we have completed
simulations in both types of micelles, we see some trends in the
positions affecting activity and toxicity. In Fig. 7, the residues
most deeply inserted into the micelle are colored red and the
residues farthest from the micelle are colored blue, with colorson of protegrins-1 in an SDS micelle.
Fig. 11. Representation of the location of the peptides in DPCmicelles. Residues
colored red are less than 16 Å from the center of the micelle; those more than
16 Å from the center but in the micelle core colored orange; residues in the
phosphate head group region; 18–21 Å from the micelle center colored yellow;
and residues in the choline head group region, between 21 and 24 Å, are colored
green. Residues in the bulk water region are colored blue.
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From the sequence alignment, we can see some trends in the
residues that interact most strongly with the interior of the
micelle. Mutations at the N- and C-termini cause changes in
the interaction patterns with the SDS micelle. The wild-type
protegrin-1 inserts strongly at Leu-5, and we see similar in-
teractions for PC107. PC107 has the C-terminal positive charge
found on PG-1 replaced with a negatively charged glutamate
residue. PC101 and PC104 have sequences similar to PC107;
however, these two peptides insert their C-terminal strand re-
sidues into the SDS micelle. This is due to the difference in
charge of the C-termini. The negative charge on PC107 is
repelled from the anionic micelle surface causing Leu-5 to be
inserted into the micelle interior. PC101 and PC104, on the
other hand are neutral at this region, and allow the hydrophobic
residues Phe-12, Val-14, and Ile-16 on PC104, to insert into the
micellar core.
It is also apparent that the mutations on the N-terminus require
these peptides to shift their interactions with the SDS micelle to
the second strand of the hairpin. The removal of two positive
charges from the N-termini of PC94 and PC98 leave the peptide
with no way to “anchor” this side of itself to the micelle surface.
For these peptides, the phenylalanine and valine residues seem to
have important interactions with bacterial membranes.
6.2. Insights into toxicity
Simulations in SDS indicate that the residues on the second
strand of the peptide are the ones that are causing toxicity. Fig.
8 shows the distances from the center of the DPC micelle for
each residue. Red is most close to the micelle center and blue is
outside of the micelle in the bulk water. Upon comparing Figs. 7
and 8, we see there is a distinct difference in the interaction
patterns for these peptides. Mainly, the first half of the hairpin
does not seem to be involved in the toxicity of the protegrins.
The valine residue analogous to PG-1′s Val-14 is deeply
inserted for each peptide, except for the significantly smaller
PC72 and PC73 (Fig. 9).
Our attempts to design new peptides will be based on
comparing the results of the interactions of the peptides in both
SDS and DPC micelles. From the results presented here, a few
rules can be determined. Of note is that there PC94 and PC98 haveFig. 10. Representation of the location of the peptides in SDS micelles. Residues
colored red are less than 17 Å from the center of the micelle; those more than
17 Å from the center but in the micelle core colored orange; residues in the head
group region, 19–22 Å from the micelle center, colored yellow; and residues
between 22 and 25 Å are colored green. Residues in the bulk water region are
colored blue.similar interactions in DPC versus SDS. This suggests that there
may not be a straightforward way to reduce the toxicity of these
peptides while retaining their antimicrobial activity. The removal
of the positive charges from theN-terminal side of the hairpin thus
may not be a beneficial mutation. Instead, we will focus on
mutations on the C-terminus of the peptide. It is of interest that
PC101 and PC104 have strong hydrophobic interactions in both
DPC and SDS for Phe-12, Val-14 and the 16th residue, threonine
or isoleucine, while PG-1 does not. The presence of a positive
change at Arg-18 on PG-1 anchors the C-terminus to the SDS
micelle surface, and prevents Phe-12, Val-14 and Val-16 from
inserting too deeply into the micelle. PC101 and PC104 do not
carry the positive charge at the C-terminus, thus allowing strong
hydrophobic interactions between the C-terminal strand and the
micelle. PC107 does not insert into this region because of the
negatively charged glutamine residue on the C-terminus. For this
reason, this sequence seems the most promising for further
mutations to lower toxicity but retain activity (Fig. 10).
From the above observations, it is apparent that there are
differences in the ways that different PG-1 mutants interact with
the different types of micelles. These differences will allow us to
modulate sequences to reduce the toxicity of the peptides and
increase or maintain their activity. We will continue to gather
information about the protegrins from the simulations of other
protegrins analogues. We will also continue to test the
sequences we have designed in the laboratory (Fig. 11).
7. Conclusions
Although the simulations of peptides with micelles success-
fully capture experimentally observed binding states, and
explain biophysical peptide–membrane interactions, there are
certain caveats which should not be overlooked. The geometry
of the spherical lipid micelle is very different than planar lipid
bilayers, and the interfacial curvature can potentially induce
peptide structures which may never be actually observed near
realistic membranes. A gradient of order parameters along the
length of the hydrocarbon lipid tails is present in real lipid
vesicles and atomistic models of lipid bilayers. This gradient
alters the flexibility of the lipid chains along the bilayer normal,
and might affect the depth of insertion of small peptides. This
structural feature is not well-modeled in micelles. Although the
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zwitterionic phospholipids, the SDS molecule is a relatively
poor representation of anionic phospholipids which carry a
phosphatidylglycerol or a phosphatidylserine headgroup. Addi-
tionally, it is not possible to investigate the simultaneous binding
of multiple peptides in micelles, something which can be done
by increasing the size of bilayer systems. Despite these
limitations, the micelles still offer efficient models of interfaces
where simulations with many different peptides can be carried
out with a high degree of confidence with respect to the sampling
of the free energy minimum conformations. In the simulations
reported in the current work, we have tried to address some of the
problems associated with peptide–membrane simulations. We
have also successfully developed elementary design rules for
better antimicrobial peptides of two key structural classes of
peptides: α-helical and β-turn. Of course, only testing those
experimentally, will provide us with the ultimate confidence in
the models, and we are working in this direction. Specifically,
data on binding energies of peptides to micelles/bilayers can
provide definitive proof of the conclusions drawn in the current
work. Meanwhile, simulations will continue to provide us with
the much-required atomistic level descriptions of peptide–
membrane interactions.
In 2001, Tieleman and Sansom, two pioneers in the area of
protein–membrane simulations, summarized that: “reliably
simulating binding to membranes, insertion into membranes
and aggregation of peptides both in and at the surface of
membrane protein remain challenging problems” [38]. Surpris-
ingly, the situation has not changed drastically since. However,
as methods for calculating free energies improve in accuracy,
and computers keep getting cheaper and faster, our ability to
address the time scales and length scales of the relevant
peptide–membrane interaction phenomena can only improve.
The future for simulations is looking fairly bright.
Acknowledgements
This work was supported by grants from NIH (GM 070989).
Computational support from the Minnesota Supercomputing
Institute (MSI) is gratefully acknowledged. This work was also
partially supported by National Computational Science Alliance
under MCB030027P and utilized the marvel cluster at the
Pittsburgh Supercomputing Center. We thank Prof. AlanWaring
for useful discussions. We also thank Prof. Ramamoorthy for
inviting us to write a paper for this special issue.
References
[1] M. Zasloff, Antimicrobial peptides of multicellular organisms, Nature 415
(2002) 389–395.
[2] D.P. Tieleman, M.S.P. Sansom, Molecular dynamics simulations of
antimicrobial peptides: from membrane binding to trans-membrane
channels, Int. J. Quant. Chem. 83 (2001) 166–179.
[3] P. La Rocca, P.C. Biggin, D.P. Tieleman, M.S.P. Sansom, Simulation
studies of the interaction of antimicrobial peptides and lipid bilayers,
Biochim. Biophys. Acta 1462 (1999) 185–200.
[4] Y. Shai, Mechanism of binding, insertion and destabilization of
phospholipid bilayer membranes by a-helical antimicrobial and cell non-selective membrane-lytic peptides, Biochim. Biophys. Acta 1462 (1999)
55–70.
[5] C.M. Shepherd, H.J. Vogel, D.P. Tieleman, Interactions of the designed
antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid
bilayers: molecular-dynamics simulations, Biochem. J. 370 (2003)
233–243.
[6] C. Appelt, F. Eisenmenger, R. Kuhne, P. Schmieder, J.A. Soderhall,
Interaction of the antimicrobial peptide cyclo(RRWWRF) with membranes
by molecular dynamics simulations, Biophys. J. 89 (2005) 2296–2306.
[7] S.K. Kandasamy, R.G. Larson, Binding and insertion of alpha-helical anti-
microbial peptides in POPC bilayers studied by molecular dynamics
simulations, Chem. Phys. Lipids 132 (2004) 113–132.
[8] S.K. Kandasamy, R.G. Larson, Molecular dynamics study of the lung
surfactant peptide SP-B1-25 with DPPC monolayers: insights into
interactions and peptide position and orientation, Biophys. J. 88 (2005)
1577–1592.
[9] H. Khandelia, Y. Kaznessis, Molecular dynamics simulations of helical
antimicrobial peptides: what do point mutations achieve? Peptides 26
(2005) 2037–2049.
[10] H. Khandelia, Y. Kaznessis, Molecular dynamics simulations of the helical
antimicrobial peptide ovispirin-1 in zwitterionic dodecylphoshocholine
micelles, J. Phys. Chem. B 109 (2005) 12990–12996.
[11] H. Khandelia, Y. Kaznessis, Molecular Dynamics Investigation of the
Influence of Anionic and Zwitterionic Interfaces on Antimicrobial
Peptides' Structure: Implications on Peptide Toxicity and Activity,
Peptides (in press).
[12] A. Langham, H. Khandelia, Y. Kaznessis, How Can a β-sheet Peptide be
Both a Potent Antimicrobial and Harmfully Toxic? Molecular Dynamics
Simulations of Protegrin-1 in Micelles, Submitted to J. Pept. Sci. (2005).
[13] M.F. Lensink, B. Christiaens, J. Vandekerckhove, A. Prochiantz, M.
Rosseneu, Penetratin–membrane association: W48/R52/W56 shield the
peptide from the aqueous phase, Biophys. J. 88 (2005) 939–952.
[14] P. Fernandez, S. Schroedle, R. Buchner, W. Kunz, Micelle and solvent
relaxation in aqueous sodium dodecylsulfate solutions, Chem. Phys.
Chem. 4 (2003) 1065–1072.
[15] A.R. Rakitin, G.R. Pack, Molecular dynamics simulations of ionic
interactions with dodecyl sulfate micelles, J. Phy. Chem., B 108 (2004)
2712–2716.
[16] T. Wymore, X.F. Gao, T.C. Wong, Molecular dynamics simulation of the
structure and dynamics of a dodecylphosphocholine micelle in aqueous
solution, J. Mol. Struct. 485–486 (1999) 195–210.
[17] T. Wymore, T.C. Wong, Molecular dynamics study of substance P peptides
partitioned in a sodium dodecylsulfate micelle, Biophys. J. 76 (1999)
1213–1227.
[18] T. Wymore, T.C. Wong, The structure and dynamics of ACTH (1–10) on
the surface of a sodium dodecylsulfate (SDS) micelle: a molecular
dynamics simulation study, J. Biomol. Struct. Dyn. 18 (2000) 461–476.
[19] C.M. Shepherd, K.A. Schaus, H.J. Vogel, Molecular dynamics study of
peptide-bilayer adsorption, Biophys. J. 80 (2001) 579–596.
[20] A. Mecke, D.K. Lee, A. Ramamoorthy, B.G. Orr, M.M. Holl Banaszak,
Membrane thinning due to antimicrobial peptide binding: an atomic force
microscopy study of MSI-78 in lipid bilayers, Biophys. J. 89 (2005)
4043–4050.
[21] R.F. Epand, A. Ramamoorthy, R.M. Epand, Membrane lipid composition
and the interaction of pardaxin: the role of cholesterol, Protein Pept. Lett.
13 (2006) 1–5.
[22] V.C. Kalfa, H.V.P. Jia, R.A. Kunkle, P.B. McCray, B.F. Tack, K.A.
Brogden, Congeners of SMAP29 kill ovine pathogens and induce
ultrastructural damage in bacterial cells, Antimicrob. Agents Chemother.
45 (2001) 3256–3261.
[23] M.V. Sawai, A.J. Waring, W.R. Kearney, P.B. McCray Jr., W.R. Forsyth,
R.I. Lehrer, B.F. Tack, Impact of single-residue mutations on the structure
and function of ovispirin/novispirin antimicrobial peptides, Protein Eng.
15 (2002) 225–232.
[24] V.N. Kokryakov, S.S. Harwig, E.A. Panyutich, A.A. Shevchenko, G.M.
Aleshina, O.V. Shamova, H.A. Korneva, R.I. Lehrer, Protegrins: leukocyte
antimicrobial peptides that combine features of corticostatic defensins and
tachyplesins, FEBS Lett. 327 (1993) 231–236.
1234 H. Khandelia et al. / Biochimica et Biophysica Acta 1758 (2006) 1224–1234[25] X.D. Qu, S.S. Harwig, W.M. Shafer, R.I. Lehrer, Protegrin structure and
activity against Neisseria gonorrhoeae, Infect. Immun. 65 (1997)
636–639.
[26] G. Drin, J. Temsamani, Translocation of protegrin I through phospholipid
membranes: role of peptide folding, Biochim. Biophys. Acta 1559 (2002)
160–170.
[27] A.D. MacKerell Jr., Molecular dynamics simulation analysis of a sodium
dodecyl sulfate micelle in aqueous solution: decreased fluidity of the
micelle hydrocarbon interior, J. Phys. Chem. 99 (1995) 1846–1855.
[28] W.L. Jorgensen, J. Chandrasekhar, J.D. Medura, R.W. Impey, M.L.
Klein, Comparison of simple potential function for simulating liquid
water, J. Chem. Phys. 79 (1983) 926–935.
[29] S. Yamaguchi, D. Huster, A.Waring, R.I. Lehrer,W.Kearney, B.F. Tack,M.
Hong, Orientation and dynamics of an antimicrobial peptide in the lipid
bilayer by solid-state NMR spectroscopy, Biophys. J. 81 (2001)
2203–2214.
[30] B.R. Brooks, R.E. Bruccoleri, B.D. Olfson, D.J. States, S. Swaminathan,
K. Karplus, CHARMM: a program for macromolecular energy, minimi-
zation, and dynamics calculations, J. Comput. Chem. 4 (1983) 187–217.
[31] W.G. Hoover, Canonical dynamics: equilibrium phase-space distributions,
Phys. Rev., A 31 (1985) 1695–1697.[32] S.E. Feller, Y. Zhang, R.W. Pastor, B.R. Brooks, Constant pressure
molecular dynamics simulation: the Langevin piston method, J. Chem.
Phys. 103 (1995) 4613–4621.
[33] U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, L.G. Pedersen,
A smooth particle mesh Ewald method, J. Chem. Phys. 103 (1995)
8577–8593.
[34] A.M. Cole, Minidefensins and other antimicrobial peptides: candidate anti-
HIV microbicides, Expert Opin. Ther. Targets 7 (2003) 329–341.
[35] S.S. Lim, Y.M. Song, M.H. Jang, Y. Kim, K.S. Hahm, S.Y. Shin, Effects
of two glycine residues in positions 13 and 17 of pleurocidin on
structure and bacterial cell selectivity, Protein Pept. Lett. 11 (2004)
35–40.
[36] K. Lee, S.Y. Shin, K. Kim, S.S. Lim, K.-S. Hahm, Y. Kim, Antibiotic
activity and structural analysis of the scorpion-derived antimicrobial
peptide IsCT and its analogs, Biochem. Biophys. Res. Commun. 323
(2004) 712–719.
[37] A. Langham, Y. Kaznessis, Effects of mutations on the C-terminus of
Protegrin-1: A molecular dynamics study, J. Mol. Sim. (in press).
[38] P.L. Rocca, P.C. Biggin, D.P. Tieleman, M.S.P. Sansom, Simulation studies
of the interaction of antimicrobial peptides and lipid bilayers, Biochim.
Biophys. Acta 1462 (1999) 185–200.
